Publication | Open Access
Preclinical safety and activity of recombinant VSV‐IFN‐β in an immunocompetent model of squamous cell carcinoma of the head and neck
23
Citations
27
References
2013
Year
The above data confirm safety and feasibility of VSV-IFN-β administration in immunocompetent animals and support its clinical evaluation in advanced human head and neck cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1